Literature DB >> 25367297

Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults.

Subhasis Mohanty1, Samit R Joshi1, Ikuyo Ueda1, Jean Wilson1, Tamara P Blevins2, Barbara Siconolfi1, Hailong Meng3, Lesley Devine4, Khadir Raddassi5, Sui Tsang1, Robert B Belshe2, David A Hafler6, Susan M Kaech7, Steven H Kleinstein8, Mark Trentalange9, Heather G Allore9, Albert C Shaw1.   

Abstract

We evaluated in vivo innate immune responses in monocyte populations from 67 young (aged 21-30 years) and older (aged ≥65 years) adults before and after influenza vaccination. CD14(+)CD16(+) inflammatory monocytes were induced after vaccination in both young and older adults. In classical CD14(+)CD16(-) and inflammatory monocytes, production of tumor necrosis factor α and interleukin 6, as measured by intracellular staining, was strongly induced after vaccination. Cytokine production was strongly associated with influenza vaccine antibody response; the highest levels were found as late as day 28 after vaccination in young subjects and were substantially diminished in older subjects. Notably, levels of the anti-inflammatory cytokine interleukin 10 (IL-10) were markedly elevated in monocytes from older subjects before and after vaccination. In purified monocytes, we found age-associated elevation in phosphorylated signal transducer and activator of transcription-3, and decreased serine 359 phosphorylation of the negative IL-10 regulator dual-specificity phosphatase 1. These findings for the first time implicate dysregulated IL-10 production in impaired vaccine responses in older adults.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  aging; cytokine; influenza vaccine; innate immunity; monocyte

Mesh:

Substances:

Year:  2014        PMID: 25367297      PMCID: PMC4366602          DOI: 10.1093/infdis/jiu573

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  37 in total

1.  ERK1/2 achieves sustained activation by stimulating MAPK phosphatase-1 degradation via the ubiquitin-proteasome pathway.

Authors:  Yun-Wei Lin; Show-Mei Chuang; Jia-Ling Yang
Journal:  J Biol Chem       Date:  2003-04-03       Impact factor: 5.157

2.  Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation.

Authors:  J M Brondello; J Pouysségur; F R McKenzie
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

3.  Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signaling.

Authors:  Yun-Wei Lin; Jia-Ling Yang
Journal:  J Biol Chem       Date:  2005-11-14       Impact factor: 5.157

4.  Essential role of MAPK phosphatase-1 in the negative control of innate immune responses.

Authors:  Konstantin V Salojin; Iris B Owusu; Karen A Millerchip; Mark Potter; Ken A Platt; Tamas Oravecz
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

5.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils.

Authors:  K Takeda; B E Clausen; T Kaisho; T Tsujimura; N Terada; I Förster; S Akira
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

6.  Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages.

Authors:  Lynn Williams; Laura Bradley; Alexandra Smith; Brian Foxwell
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

7.  Mortality associated with influenza and respiratory syncytial virus in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Nancy Cox; Larry J Anderson; Keiji Fukuda
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

8.  Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses.

Authors:  Hongbo Chi; Sean P Barry; Rachel J Roth; J Julie Wu; Elizabeth A Jones; Anton M Bennett; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

9.  MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock.

Authors:  Qun Zhao; Xianxi Wang; Leif D Nelin; Yongxue Yao; Ranyia Matta; Mary E Manson; Reshma S Baliga; Xiaomei Meng; Charles V Smith; John A Bauer; Cheong-Hee Chang; Yusen Liu
Journal:  J Exp Med       Date:  2005-12-27       Impact factor: 14.307

10.  Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock.

Authors:  Michael Hammer; Jörg Mages; Harald Dietrich; Angela Servatius; Norma Howells; Andrew C B Cato; Roland Lang
Journal:  J Exp Med       Date:  2005-12-27       Impact factor: 14.307

View more
  33 in total

Review 1.  Aging, cytomegalovirus (CMV) and influenza vaccine responses.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and NK Cell Function.

Authors:  Helen R Wagstaffe; Harry Pickering; Joanna Houghton; Jason P Mooney; Asia-Sophia Wolf; Natalie Prevatt; Ron H Behrens; Martin J Holland; Eleanor M Riley; Martin R Goodier
Journal:  J Immunol       Date:  2019-08-19       Impact factor: 5.422

3.  Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease.

Authors:  Padmini S Pillai; Ryan D Molony; Kimberly Martinod; Huiping Dong; Iris K Pang; Michal C Tal; Angel G Solis; Piotr Bielecki; Subhasis Mohanty; Mark Trentalange; Robert J Homer; Richard A Flavell; Denisa D Wagner; Ruth R Montgomery; Albert C Shaw; Peter Staeheli; Akiko Iwasaki
Journal:  Science       Date:  2016-04-22       Impact factor: 47.728

Review 4.  Paradoxical changes in innate immunity in aging: recent progress and new directions.

Authors:  Ruth R Montgomery; Albert C Shaw
Journal:  J Leukoc Biol       Date:  2015-07-17       Impact factor: 4.962

Review 5.  COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside.

Authors:  David Sulzer; Angelo Antonini; Valentina Leta; Anna Nordvig; Richard J Smeyne; James E Goldman; Osama Al-Dalahmah; Luigi Zecca; Alessandro Sette; Luigi Bubacco; Olimpia Meucci; Elena Moro; Ashley S Harms; Yaqian Xu; Stanley Fahn; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2020-08-20

6.  Cytokine production in whole-blood cultures following immunization with an influenza vaccine.

Authors:  Tetsuo Nakayama; Takuji Kumagai; Yasuyo Kashiwagi; Hironori Yoshii; Kenta Honjo; Ritsuko Kubota-Koketsu; Yoshinobu Okuno; Shigeru Suga
Journal:  Hum Vaccin Immunother       Date:  2018-08-28       Impact factor: 3.452

7.  B Cell-Specific Biomarkers for Optimal Antibody Responses to Influenza Vaccination and Molecular Pathways That Reduce B Cell Function with Aging.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

Review 8.  Inflammaging decreases adaptive and innate immune responses in mice and humans.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Biogerontology       Date:  2015-04-29       Impact factor: 4.277

Review 9.  Host Factors Impact Vaccine Efficacy: Implications for Seasonal and Universal Influenza Vaccine Programs.

Authors:  Santosh Dhakal; Sabra L Klein
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

10.  Seasonal Variability and Shared Molecular Signatures of Inactivated Influenza Vaccination in Young and Older Adults.

Authors:  Stefan Avey; Subhasis Mohanty; Daniel G Chawla; Hailong Meng; Thilinie Bandaranayake; Ikuyo Ueda; Heidi J Zapata; Koonam Park; Tamara P Blevins; Sui Tsang; Robert B Belshe; Susan M Kaech; Albert C Shaw; Steven H Kleinstein
Journal:  J Immunol       Date:  2020-02-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.